Medical technology and pharmaceutical companies are looking forward to a promising future. Technological innovation power and excellence in pharmacological research are enabling, ever more, excellent treatment successes.
At the same time, hardly any other industry is facing such historic challenges. The general digitization trend is joined by a whole range of industry-specific issues, that will lead to fundamental changes in the coming years.
Exploding healthcare costs combined with enormous quality and efficiency pressure, massively tightening regulatory frameworks, and many other factors are forcing companies to constantly question and realign their traditional business models and corporate strategies.
In this challenging scenario, companies in the healthcare industry need, more than ever, innovative strategies and top executives who can drive and actively shape associated change.